Please follow the instructions listed below:
● All abstracts (published or from ongoing studies) can be submitted through our Abstract Submission Portal (click here).
● Abstracts must be received by the announced deadline End of Business day (CET). Abstracts received after the deadlines will not be considered. If you experience any difficulties when submitting your abstract, please contact email@example.com.
● Submission of an abstract acknowledges the acceptance for the abstract to be published in the official meeting publications.
● Co-author approval is assumed to be approved with abstract submission.
● Presenting authors must be registered participants at least 1 month before the conference. If this is not possible due to circumstances, please contact us at firstname.lastname@example.org.
● Abstract submitters will be required to disclose any conflict of interests in the submission form.
● All applicants must currently work or study in the field of respiratory infectious diseases, and must provide information regarding position/title.
● Abstracts must be related to RSV and fit to 1 of the 4 categories:
● Vaccines, Therapies & Treatments
● Clinical Studies
● Evolution & Epidemiology
● Virology & Immunology
● Abstracts must be submitted and presented in English.
● Abstracts must be about recent data.
● Maximum of 250 words, otherwise abstract will not be accepted.